Clinical Trial Update: Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating regorafenib with 5-fluorouracil/leucovorin beyond progression in metastatic colorectal cancer has been terminated; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil/Leucovorin (5-FU/leucovorin)
• Regorafenib (regorafenib)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-02-07